SCPH: scPharmaceuticals Inc. Stock

by  •  • Comments Off on SCPH: scPharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 169.14
Enterprise Value ($M) 128.75
Book Value ($M) 30.71
Book Value / Share 0.61
Price / Book 5.51
NCAV ($M) 28.97
NCAV / Share 0.58
Price / NCAV 5.84

Profitability (mra)
Return on Invested Capital (ROIC) -0.96
Return on Assets (ROA) -0.85
Return on Equity (ROE) -2.15

Liquidity (mrq)
Quick Ratio 6.89
Current Ratio 8.08

Balance Sheet (mrq) ($M)
Current Assets 123.33
Assets 125.07
Liabilities 94.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-15 13G/A King Luther Capital Management Corp 5.80 24.16
11-14 13G/A Lytton Laurence W 5.90 61.35
11-14 13G/A Lundbeckfond Invest A/S 5.70 -10.05
08-15 13D/A Orbimed Advisors Llc 12.10 8.99
04-05 13G/A BlackRock, Inc. 4.99 -3.32
02-14 13G/A Armistice Capital, Llc 0.00 -100.00
02-14 13G/A 5AM Ventures IV, L.P. 3.30 -56.10
02-12 13G Rubric Capital Management LP 9.76
02-07 13G/A Hirschman Orin 8.70 21.82
02-02 13G/A Cowen Financial Products LLC 0.00 -100.00
2024-01-12 13G/A Millennium Management Llc 1.00 -79.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-31 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 62,316 297,584 20.94
2025-01-14 46,386 165,513 28.03
2025-01-13 46,204 177,253 26.07
2025-01-10 103,839 352,149 29.49

(click for more detail)

Similar Companies
RVMD – Revolution Medicines, Inc. RXRX – Recursion Pharmaceuticals, Inc.
SANA – Sana Biotechnology, Inc. SDGR – Schrödinger, Inc.
SLDB – Solid Biosciences Inc.


Financial data and stock pages provided by
Fintel.io